TxCell
Biotechnology ResearchPays de la Loire, France2-10 Employees
TxCell is now a subsidiary of Sangamo Therapeutics, Inc. and has been renamed Sangamo Therapeutics France.
Recent Industry Expansion As a biotech research company now integrated into Sangamo Therapeutics, there are opportunities to leverage Sangamo's broader portfolio and network to promote collaborative projects or service offerings in gene therapy and personalized medicine.
Technology Adoption With a tech stack including Angular, Creatio, and collaboration tools like Postman, there is potential to offer tailored software solutions or consulting services to optimize their research and operational workflows.
Market Positioning Operating within a competitive landscape with similar small-scale biotech firms, TxCell can benefit from targeted outreach emphasizing innovative research techniques, funding opportunities, or partnership prospects aligned with biotech advancements.
Funding and Revenue Growth Given their modest revenue of up to one million dollars, there is a strong opportunity to assist with grant applications, fundraising strategies, or commercialization services that can help scale their innovations and revenue streams.
Potential Collaboration Areas Considering the company's recent context and industry trends, prospects exist for engagement in AI-driven biotech solutions, partnership opportunities with digital learning platforms, or supporting next-generation research tools in line with their biotech focus.
TxCell uses 8 technology products and services including Creatio, Postman, Microsoft Visio, and more. Explore TxCell's tech stack below.
| TxCell Email Formats | Percentage |
| First.Last@txcell.com | 62% |
| Last@txcell.com | 38% |
| FLast@linkedin.com | 80% |
| FiLast@linkedin.com | 12% |
| LastFir@linkedin.com | 4% |
| FirLast@linkedin.com | 4% |
Biotechnology ResearchPays de la Loire, France2-10 Employees
TxCell is now a subsidiary of Sangamo Therapeutics, Inc. and has been renamed Sangamo Therapeutics France.
TxCell's revenue is estimated to be in the range of $1M
TxCell's revenue is estimated to be in the range of $1M